TXMD

Therapeuticsmd Inc

2.170

-0.110-4.82%

After Hours: 2.170 0.000 0.01%18:05 03/13 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE2.281/2.280

TODAY RANGE2.150-2.281

VOL21.25K

MARKET CAP25.12M

52 WEEK RANGE0.7200-2.950

AVG VOL (3M)81.93K

% TURNOVER0.18%

TURNOVER--

P/E (TTM)83.14

% RANGE5.74%

EPS(TTM)0.0261

P/E(FORWARD)13.56

P/B0.9151

BVPS2.371

DIVIDEND--

P/S14.21

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP24.71M

SHARES OUTSTANDING11.57M

NEXT EARNINGS03/25-03/30

FREE FLOAT11.39M

LOT SIZE1

EX-DATE05/09/2022

News

Press Releases

Financial Reports

Profile

Dow Jones·20h ago
TherapeuticsMD Inc. Stock Sheds 4.8%, Underperforms Market
Dow Jones·02/09 21:33
TherapeuticsMD Inc. Stock Climbs 8.3%, Outperforms Market
Dow Jones·02/02 21:35
TherapeuticsMD Inc. Stock Rallies 4.6%, Outperforms Market
Dow Jones·01/30 21:34
TherapeuticsMD Inc. Stock Slips 6.1%, Underperforms Market
Dow Jones·01/29 21:34
TherapeuticsMD Inc. Stock Climbs 7.5%, Outperforms Market
Dow Jones·01/28 21:32
TherapeuticsMD Inc. Stock Slides 11.6%, Underperforms Market
Dow Jones·01/27 21:32
TherapeuticsMD Inc. Stock Slides 12.6%, Underperforms Market
Dow Jones·01/26 21:32
TherapeuticsMD Inc. Stock Advances 6.1%, Outperforms Market
Dow Jones·01/15 21:34
TherapeuticsMD Inc. Stock Climbs 4.7%, Outperforms Market
Dow Jones·01/12 21:35
TherapeuticsMD Inc. Stock Sheds 3.7%, Underperforms Market
Dow Jones·01/09 21:34
TherapeuticsMD Inc. Stock Rallies 4.9%, Outperforms Market
NASDAQ·01/08 03:14
After-Hours Gainers: ALXO, GMED, ACRV, And Biotech Peers Rally On Trial Data And Earnings Updates
Dow Jones·01/06 21:32
TherapeuticsMD Inc. Stock Rallies 13.3%, Outperforms Market
Dow Jones·01/05 21:32
TherapeuticsMD Inc. Stock Advances 9.1%, Outperforms Market
Dow Jones·12/30/2025 21:34
TherapeuticsMD Inc. Stock Falls 2.4%, Underperforms Market

Same Industry

Name/Symbol

Change%

Price

TXMD

MCK

BIIB

AMGN

SHPG

CELG-RT

CELG

LLY

JNJ

ABBV

ZTS

GILD

NVO

BMY

ALXN

PFE

SNY

GCVRZ

Novartis

NVS

-0.53%

153.44

RDY

GSK

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.